The burden of atrial fibrillation (AF) is increasing worldwide; however, most existing data on AF epidemiology are from Western regions. According to our analyses, the estimated absolute prevalence of AF in the Asia–Pacific region in 2023 was approximately 80 million, which is much higher than has been calculated for other global regions.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Rahman, F., Kwan, G. F. & Benjamin, E. J. Global epidemiology of atrial fibrillation. Nat. Rev. Cardiol. 11, 639–654 (2014).
Odutayo, A. et al. Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis. BMJ 354, i4482 (2016).
Gallagher, C. et al. Increasing trends in hospitalisations due to atrial fibrillation in Australia from 1993 to 2013. Heart 105, 1358–1363 (2019).
Chugh, S. S. et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation 129, 837–847 (2014).
Dewland, T. A., Olgin, J. E., Vittinghoff, E. & Marcus, G. M. Incident atrial fibrillation among Asians, Hispanics, blacks, and whites. Circulation 128, 2470–2477 (2013).
Turakhia, M. P. et al. Contemporary prevalence estimates of undiagnosed and diagnosed atrial fibrillation in the United States. Clin. Cardiol. 46, 484–493 (2023).
Krijthe, B. P. et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur. Heart J. 34, 2746–2751 (2013).
Kornej, J., Börschel, C. S., Benjamin, E. J. & Schnabel, R. B. Epidemiology of atrial fibrillation in the 21st century: novel methods and new insights. Circ. Res. 127, 4–20 (2020).
Chan, N. Y. et al. 2021 Asia Pacific Heart Rhythm Society (APHRS) practice guidance on atrial fibrillation screening. J. Arrhythm. 38, 31–49 (2021).
Acknowledgements
C.X.W. and P.S. are supported by Investigator Grant Fellowships from the National Health and Medical Research Council of Australia.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
E.-K.C. declares research grants or speaking fees from Abbott, Bayer, Biosense Webster, BMS/Pfizer, Chong Kun Dang, Daewoong Pharmaceutical, Daiichi Sankyo, DeepQure, Dreamtech, Jeil Pharmaceutical, Medtronic, Samjinpharm, Samsung Electronics, Seers Technology and Skylabs. K.I. declares honoraria from Boston Scientific, Daiichi Sankyo, Johnson & Johnson and Medtronic. P.S. declares that the University of Adelaide, Australia, has received on his behalf research grants from Abbott, Boston Scientific, Becton Dickinson and Medtronic, and reports serving on advisory boards for Abbott, Boston Scientific, CathRx, Medtronic and Pacemate. The other authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Related links
World Population Prospects: https://population.un.org/wpp/
Rights and permissions
About this article
Cite this article
Wong, C.X., Tse, H.F., Choi, EK. et al. The burden of atrial fibrillation in the Asia–Pacific region. Nat Rev Cardiol 21, 841–843 (2024). https://doi.org/10.1038/s41569-024-01091-1
Published:
Issue date:
DOI: https://doi.org/10.1038/s41569-024-01091-1
